During the past decade, Mountain View Clinical Research Inc conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 13 clinical trials were completed, i.e. on average, 35.1% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 8 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mountain View Clinical Research Inc" #1 sponsor was "Eli Lilly and Company" with 16 trials, followed by "Pfizer" with 7 trials sponsored, "Arrowhead Pharmaceuticals" with 3 trials sponsored, "Ironwood Pharmaceuticals, Inc." with 2 trials sponsored and "Abbott Nutrition" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mountain View Clinical Research Inc" #1 collaborator was "Allergan Sales, LLC" with 2 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Curebase Inc." with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Mountain View Clinical Research Inc" are "Migraine" (6 trials), "Obesity" (4 trials), "Overweight" (4 trials), "Type 2 Diabetes" (4 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Mountain View Clinical Research Inc" in a lesser frequency.

Most popular intervention types in "Mountain View Clinical Research Inc" are "Drug" (34 trials), "Other" (7 trials), "Biological" (5 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Tirzepatide" (8 trials), "ARO-APOC3" (3 trials), "Lasmiditan" (3 trials) and "Galcanezumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mountain View Clinical Research Inc" are 41 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mountain View Clinical Research Inc". undefined are not yet recruiting, 12 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 14 completed trials in Mountain View Clinical Research Inc, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Mountain View Clinical Research Inc, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".